Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CHER: Early ART Strategies in HIV-Infected Infants
NCT00102960Phase 3Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Jul 2005
- Primary completion
- Sep 2012
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of zidovudine, lamivudine, lopinavir + ritonavir in human immunodeficiency virus infection (HIV), sponsored by National Institute of Allergy and Infectious Diseases. Started Jul 2005; status: completed.
02
Drugs
zidovudinelamivudinelopinavir + ritonavir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00102960.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00102960.